Promise Pharmacy
- Pharmacy Profile Name: Promise Pharmacy, LLC
- Website: promisepharmacy.com
- Pharmacy Type: 503A sterile compounding pharmacy
- Lead Pharmacist: Amy Patel (25+ years sterile compounding experience)
- Accreditations: LegitScript certified
- GLP-1 Compounding: Weight loss and peptides confirmed as active service areas
- Licensed: 42 states
- Clinic Partners: 600+
About the Pharmacy
At Promise Pharmacy, the dedicated team of hormone health specialists is led by Amy Patel, a seasoned expert in sterile compounding with more than 25 years of experience.
Trusted by 600+ clinics, Promise Pharmacy operates as a 503A compounding operation with 42 state licenses, next-day shipping, and a unified portal for hormone health, weight management, and more.
Promise Pharmacy is built explicitly around the B2B telehealth and clinic partnership model rather than direct patient retail. Its infrastructure — including portal integration, ePrescribe support, Life File compatibility, API connectivity, and a dedicated tech team — reflects a pharmacy designed to plug into telehealth workflows at scale. Promise Pharmacy is described as an independent full-service pharmacy providing quality compounded medication solutions to integrative and functional medicine practitioners, weight management clinics, age management practices, ophthalmologists, dermatologists, and plastic surgeons nationwide.
GLP-1 Compounding
Promise Pharmacy supports a broad set of therapies including weight loss, peptides, TRT, BHRT, ED, hair loss, and dermatology — with additional categories available based on partner needs. Personalized formulations support metabolism, appetite control, and sustainable weight goals.
Weight loss and GLP-1/peptide compounding are core to Promise Pharmacy’s telehealth partnership offering. While the pharmacy does not publish a specific list of GLP-1 compounds on its public-facing website, its positioning toward weight management clinics and telehealth platforms, combined with its sterile compounding capability, indicates active GLP-1 fulfillment. Patients should confirm with their provider or directly with Promise Pharmacy what formulations are currently available given the post-shortage regulatory environment.
Type of Pharmacy
Promise Pharmacy is a 503A state-licensed sterile compounding pharmacy. This means it prepares patient-specific prescriptions from individual prescriber orders rather than producing bulk batches for general distribution. Its sterile compounding capability — confirmed through its lead pharmacist’s 25+ years of sterile compounding experience and its positioning for injectable products — is essential for GLP-1 weight loss formulations.
Promise Pharmacy is LegitScript certified, a credential important for telemedicine partners who require that certification. No PCAB or NABP accreditation was found in publicly available records as of March 2026. No FDA Warning Letter or enforcement action was found for Promise Pharmacy in FDA public records as of March 2026.
States Licensed In
Promise Pharmacy currently ships to 42 states. This represents one of the broader geographic footprints among 503A compounders in this series, though it falls short of the full 50-state coverage offered by larger national operations. Patients in states outside Promise Pharmacy’s shipping coverage would need to be routed to an alternate pharmacy.
Telehealth Providers They Work With
Promise Pharmacy is explicitly positioned as a telehealth infrastructure partner rather than a consumer-facing pharmacy. Promise Pharmacy aligns with providers’ current workflows through options including its ordering portal, ePrescribe, Life File, and other integration pathways — supported by a dedicated tech team. Most orders ship within 24–72 hours, depending on medication type, verification requirements, and partner account setup.
No specific named telehealth platform partnerships are publicly disclosed. The 600+ clinic partner figure suggests an active and distributed provider network across weight management, integrative medicine, and age management practices, with the business model favoring unnamed B2B relationships over public co-branding.
Pricing from Reviews
Promise Pharmacy does not publish consumer-facing pricing. The pharmacy emphasizes competitive pricing that improves partner bottom lines and patient outcomes, consistent with a wholesale or discounted partner pricing model rather than retail-facing price lists. GLP-1 pricing would flow through the prescribing clinic or telehealth platform.
Overall Reviews
Promise Pharmacy does not have a large public consumer review profile given its clinic-first B2B model. Its 600+ clinic partnerships and LegitScript certification suggest meaningful scale and operational credibility within the telehealth pharmacy supply chain. No significant safety complaints or adverse event reports were found in public records. No FDA enforcement action was found as of March 2026.





